Stocktoria

Xtant Medical Holdings, Inc. XTNT

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2010-06-30 · LEI

Xtant Medical Holdings, Inc. statistics & valuation

Market cap$63.1M
P / E12.7×
P / S0.5×
P / B1.2×
P / FCF6.2×
Net margin3.7%
Return on equity9.8%
FCF margin7.6%
Net cash$6.0M
Net debt / EBITDA-0.5×
Enterprise value USD$57.1M
EV / EBITDA4.6×
Earnings yield EBIT/EV12.8%
Return on capital11.3%
Graham number +27.4%$0.48

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($0.48); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-21.70% -63.40% -97.10% -12.70% -13.20% -8.80% -14.60% 0.70% -14.00% 3.70% 2016201720182019202020212022202320242025
Gross margin (%)
69.20% 60.60% 60.20% 65.70% 64.50% 58.80% 55.40% 60.80% 58.20% 62.90% 2016201720182019202020212022202320242025
Operating margin (%)
-8.40% -45.80% -83.20% -3.50% -1.40% -7.00% -11.70% -11.10% -10.30% 5.40% 2016201720182019202020212022202320242025
Return on equity (%)
-48.40% -15.70% -24.80% 1.30% -38.30% 9.80% 2016201720182019202020212022202320242025
Shares outstanding
1.4M 1.5M 13.2M 13.2M 77.6M 87.1M 108.9M 130.2M 139.0M 150.0M 2016201720182019202020212022202320242025
Net debt ($)
$116.6M $135.1M $71.1M $71.0M -$6.5M -$10.6M $11.5M $15.8M -$6.0M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-13.50% -49.60% -151.00% -19.00% -16.90% -8.90% -14.10% 0.70% -17.50% 5.30% 2016201720182019202020212022202320242025
Free cash flow margin (%)
0.80% -2.00% -4.30% -3.00% -12.30% -12.00% -13.70% 7.60% 2016201720182019202020212022202320242025
Debt / equity (×)
0.38× 0.28× 0.33× 0.51× 0.22× 2016201720182019202020212022202320242025
EPS ($)
-$18.46 -$34.76 -$5.97 -$0.63 -$0.25 -$0.06 -$0.09 $0.01 -$0.12 $0.03 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin62.9%58.2%60.8%55.4%58.8%64.5%65.7%60.2%60.6%69.2%
Operating margin5.4%-10.3%-11.1%-11.7%-7.0%-1.4%-3.5%-83.2%-45.8%-8.4%
Net margin3.7%-14.0%0.7%-14.6%-8.8%-13.2%-12.7%-97.1%-63.4%-21.7%
FCF margin7.6%-13.7%-12.0%-12.3%-3.0%-4.3%-2.0%0.8%——
Return on assets5.3%-17.5%0.7%-14.1%-8.9%-16.9%-19.0%-151.0%-49.6%-13.5%
Return on equity9.8%-38.3%1.3%-24.8%-15.7%-48.4%18.6%160.1%89.3%275.6%
Debt / equity0.22×0.51×0.33×0.28×0.38×—-1.72×-1.78×-2.35×-16.85×
Current ratio2.652.352.823.244.001.223.432.881.541.57

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.